Related Experiment Video
Updated: Mar 28, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Percutaneous Coronary Intervention Followed by Minimally Invasive Mitral Valve Surgery in Ischemic Mitral
Christos G Mihos1, Orlando Santana, Andrés M Pineda
1From the *Division of Cardiology, Columbia University, Mount Sinai Heart Institute, Miami Beach, FL USA; †Columbia University Medical Center, New York, NY USA; and ‡Department of Anesthesia, Mount Sinai Medical Center, Miami Beach, FL USA.
Insights
A staged treatment for coronary artery disease and ischemic mitral regurgitation (IMR) involving percutaneous coronary intervention (PCI) followed by valve surgery shows low perioperative risk and good midterm survival.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Cardiac Valve Disease
Background:
- Optimal treatment for coronary artery disease (CAD) with severe ischemic mitral regurgitation (IMR) is debated.
- Combined surgical revascularization and valve repair/replacement via sternotomy is standard but carries high risk.
- A staged approach using percutaneous coronary intervention (PCI) followed by minimally invasive valve surgery may offer an alternative.
Purpose of the Study:
- To evaluate the safety and efficacy of a staged treatment strategy for patients with CAD and severe IMR.
- To compare this staged approach with traditional combined surgery.
Main Methods:
- Retrospective analysis of 31 consecutive patients with CAD and severe IMR.
- Patients underwent PCI followed by minimally invasive valve surgery between February 2009 and April 2014.
- Data collected included demographics, procedural details, perioperative outcomes, and long-term survival.
Main Results:
- Mean age was 72 years, LVEF 35%. STS predicted mortality was 5.1%.
- PCI was performed first, followed by valve surgery within 36 days.
- 30-day mortality was 3%, with low rates of acute kidney injury and no strokes. 5-year survival was 80%.
Conclusions:
- A staged PCI and minimally invasive valve surgery approach is feasible for CAD patients with IMR.
- This strategy demonstrates low perioperative morbidity and favorable midterm survival rates.
- This approach may be a viable alternative to combined median sternotomy procedures.
Objective:
The optimal treatment strategy in patients with coronary artery disease and ischemic mitral regurgitation (IMR) remains controversial. A staged approach of percutaneous coronary intervention (PCI) followed by minimally invasive valve surgery, rather than combined median sternotomy coronary artery bypass and valve surgery, may be a viable alternative.
Methods:
We retrospectively evaluated 31 consecutive patients with coronary artery disease and severe IMR who underwent a staged procedure at our institution between February 2009 and April 2014.
Results:
The mean ± SD age, preoperative left ventricular ejection fraction, and mitral regurgitation grade were 72 ± 7 years, 35% ± 11%, and 3.6 ± 0.6, respectively. The mean ± SD Society of Thoracic Surgeons-predicted mortality score was 5.1% ± 4.2%. Percutaneous coronary intervention was performed for 1- and 2-vessel disease in 22 patients (71%) and 9 patients (29%), respectively, with 23 patients (74%) having drug-eluting stents placed. Minimally invasive valve surgery was performed within a median of 36 days after PCI, with 61% of the patients being on dual antiplatelet therapy. Postoperatively, there was 1 case of acute kidney injury, 1 case of reoperation for bleeding, and no cerebrovascular accidents. The 30-day mortality was 3%. The median total hospital length of stay was 8 days (interquartile range, 7-10). At a mean ± SD follow-up of 2.4 ± 1.6 years, 2 patients required PCI for target-vessel revascularization. Actuarial survival at 1 and 5 years was 84% and 80%, respectively.
Conclusions:
A staged approach in patients with coronary artery disease and IMR can be performed with a low perioperative morbidity and good midterm survival.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management

